Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndrome
- PMID: 8793455
- DOI: 10.1183/09031936.96.09050939
Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndrome
Abstract
Previous studies have generally shown poor effective long-term compliance with nasal continuous positive airway pressure (nCPAP) in patients with obstructive sleep apnoea syndrome (OSAS). We performed a retrospective study of patients treated with nCPAP for more than one year. Compliance was defined as the average number of hours of nCPAP use per day, where hours of use were obtained from the built-in time counter of the nCPAP device, after deduction of the 10% difference between effective use and time counters previously shown by others. We present data on the first 95 patients for whom results were available. The follow-up period was 784 +/- 366 (mean +/- SD) days for the whole group. Compliance was 5 +/- 1.8 h. For a subgroup of 36 patients, we had data on two consecutive follow-up periods (673 +/- 235 and 390 +/- 147 days for the first and second period, respectively). Compliance remained stable (5.2 +/- 1.5 and 5 +/- 2.3 h, respectively). For the whole group, a significant correlation was found between compliance and sleep fragmentation expressed as the movement arousal index (r = 0.226). During a similar 3 year period, 155 patients with a confirmed diagnosis of OSAS were offered a nCPAP trial. CPAP was actually delivered for home use to 117 patients (76%). During this same 3 year period, only 21 patients out of a total of 192 followed-up in our institution quit treatment, mainly due to intolerance or cure. These results indicate that in a nonselected group of obstructive sleep apnoea syndrome patients a high and stable compliance with nasal continuous positive pressure can be achieved, contradicting recent results of other series.
Similar articles
-
[Results of 248 patients with sleep apnea syndrome treated by continuous positive pressure ventilation between 1990 and 1995. A study of compliance and outcome of the apnea-hypopnea index].Rev Mal Respir. 2000 Apr;17(2):467-74. Rev Mal Respir. 2000. PMID: 10859765 French.
-
[Therapy with nasal CPAP (continuous positive airway pressure) in patients with obstructive sleep apnea syndrome (OSAS). I: Long-term acceptance of nasal CPAP].Laryngorhinootologie. 1997 Sep;76(9):550-3. doi: 10.1055/s-2007-997477. Laryngorhinootologie. 1997. PMID: 9417184 German.
-
[Therapy with nasal CPAP (continuous positive airway pressure) in patients with obstructive sleep apnea syndrome (OSAS). II: Side-effects of nCPAP therapy. Effect on long-term acceptance].Laryngorhinootologie. 1997 Oct;76(10):608-13. doi: 10.1055/s-2007-997488. Laryngorhinootologie. 1997. PMID: 9445527 Review. German.
-
Objective patient compliance in long-term use of nCPAP.Eur Respir J. 1996 Nov;9(11):2356-9. doi: 10.1183/09031936.96.09112356. Eur Respir J. 1996. PMID: 8947085
-
[Nasal continuous positive airway pressure and noninvasive positive ventilation in the treatment of sleep apnea/hypopnea syndrome].Nihon Rinsho. 2000 Aug;58(8):1675-9. Nihon Rinsho. 2000. PMID: 10944933 Review. Japanese.
Cited by
-
Oxygen efficient respiratory Aid (OxEraTM) device: A safety study.Afr J Emerg Med. 2022 Sep;12(3):172-176. doi: 10.1016/j.afjem.2022.03.003. Epub 2022 May 20. Afr J Emerg Med. 2022. PMID: 35611145 Free PMC article.
-
Lateral pharyngoplasty vs. traditional uvulopalatopharyngoplasty for patients with OSA: systematic review and meta-analysis.Sleep Breath. 2022 Dec;26(4):1539-1550. doi: 10.1007/s11325-021-02520-y. Epub 2022 Jan 3. Sleep Breath. 2022. PMID: 34978022 Review.
-
Access to CPAP treatment in patients with moderate to severe sleep apnea in a Latin American City.Sleep Sci. 2018 May-Jun;11(3):174-182. doi: 10.5935/1984-0063.20180032. Sleep Sci. 2018. PMID: 30455850 Free PMC article.
-
The use of drug-induced sleep endoscopy in England and Belgium.Eur Arch Otorhinolaryngol. 2018 May;275(5):1335-1342. doi: 10.1007/s00405-018-4939-y. Epub 2018 Mar 19. Eur Arch Otorhinolaryngol. 2018. PMID: 29556753 Free PMC article.
-
The Combination of Supplemental Oxygen and a Hypnotic Markedly Improves Obstructive Sleep Apnea in Patients with a Mild to Moderate Upper Airway Collapsibility.Sleep. 2016 Nov 1;39(11):1973-1983. doi: 10.5665/sleep.6226. Sleep. 2016. PMID: 27634790 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical